vijay bankda's most recent trade in Syncom Formulation (India) Ltd. was a Acquisition of 32,500,000 Equity Shares done at an average price of Rs. 2.5 . Disclosure was reported to the exchange on Feb. 28, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
vijay bankda's has made SAST transactions in Syncom Formulation (India) Ltd. recently where a Acquisition of 13,500,000 shares done . Disclosure was reported to the exchange on June 9, 2022.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syncom Formulation | Vijay Shankarlal Bankda & PACs | Promoter | Acquisition | 10 Jun 2022 | 13,500,000 | 260,991,699 (27.77%) | 1.44% | - | 28 May 2022 28 May 2022 |
SAST (29(2)) | - | Pref. Allotment | |
Syncom Formulation | Asha Vijay Bankda | Promoter Group | Acquisition | 28 Feb 2022 | 32,500,000 | 32,554,319 (3.77%) | 3.92% | 2.5 | 82,225,000 | 25 Feb 2022 25 Feb 2022 |
Insider Trading | Equity Shares | Conversion of security |